Literature DB >> 24880985

TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review.

Tony Ibrahim1, Charbel Yazbeck, Georges Maalouly, Maria Baz, Fady Haddad, Chadi Sabbagh, Georges Chahine.   

Abstract

BACKGROUND: The role of genetic factors in colorectal cancer pathogenesis is widely accepted. Polymorphisms are actually thought to play a role in the unexplained colorectal cancer (CRC) susceptibility. There is conflicting data regarding the role of the transforming growth factor beta receptor 1 polymorphism 6A (TGFBR1*6A) in the increased incidence of CRC.
PURPOSE: Our aim is to test the association between this polymorphism and sporadic/familial CRC in the Lebanese population paying attention to lead time bias in the control group. This is a case-control study conducted in two Lebanese hospital centers.
MATERIALS AND METHODS: Cases were diagnosed with CRC during the period of 1 year prior to the study. Controls were healthy subjects aged >50 years with a history of normal colonoscopy during the period of 5 years prior to the beginning of the study. A total of 96 cases (57 sporadic/39 familial) and 97 controls were genotyped. The odds ratios for 6A carrier status was statistically significant for sporadic CRC, odds ratio (OR) = 2.314 (95 % confidence interval (CI) 1.030-5.195) but not for familial CRC.
RESULTS: No association was found between 6A carrier status and mean age at diagnosis of CRC. This is the first article in the literature to evaluate the association between 6A polymorphism and total, sporadic, and familial CRC in a single study with reduction of bias in the control group. Results are in conjunction with other studies and meta-analysis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24880985     DOI: 10.1007/s12029-014-9625-8

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  28 in total

1.  TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.

Authors:  C Fiocchi
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.

Authors:  Johanna Skoglund; Bo Song; Johan Dalén; Stefan Dedorson; David Edler; Fredrik Hjern; Jörn Holm; Claes Lenander; Ulrik Lindforss; Nils Lundqvist; Hans Olivecrona; Louise Olsson; Lars Påhlman; Jörgen Rutegård; Kennet Smedh; Anders Törnqvist; Richard S Houlston; Annika Lindblom
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

3.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

4.  TbetaR-I(6A) polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Correspondence re: B. Pasche et al. Type I TbetaR-I(6A) Is a Candidate Tumor Susceptibility Allele. Cancer Res., 58: 2727-2732, 1998.

Authors:  A M Stefanovska; G D Efremov; A J Dimovski; D Jasar; G Zografski; T Josifovski; M Panovski; R Jankova; M Spiroski
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

5.  TbetaR-I(6A) is a candidate tumor susceptibility allele.

Authors:  B Pasche; P Kolachana; K Nafa; J Satagopan; Y G Chen; R S Lo; D Brener; D Yang; L Kirstein; C Oddoux; H Ostrer; P Vineis; L Varesco; S Jhanwar; L Luzzatto; J Massagué; K Offit
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

6.  Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer.

Authors:  W S Samowitz; K Curtin; M F Leppert; M L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2001-12       Impact factor: 5.006

7.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

8.  TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.

Authors:  Virginia G Kaklamani; Nanjiang Hou; Yiansong Bian; Jennifer Reich; Kenneth Offit; Loren S Michel; W S Rubinstein; Alfred Rademaker; Boris Pasche
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 44.544

Review 9.  Role of transforming growth factor-beta superfamily signaling pathways in human disease.

Authors:  Kelly J Gordon; Gerard C Blobe
Journal:  Biochim Biophys Acta       Date:  2008-02-11

Review 10.  Familial adenomatous polyposis.

Authors:  Finlay Macrae; D du Sart; S Nasioulas
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

View more
  3 in total

1.  TGFBR1*6A is a potential modifier of migration and invasion in colorectal cancer cells.

Authors:  Rui Zhou; Ying Huang; Boran Cheng; Yulei Wang; Bin Xiong
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

2.  Functional Linkage of RKIP to the Epithelial to Mesenchymal Transition and Autophagy during the Development of Prostate Cancer.

Authors:  Mahmoud Ahmed; Trang Huyen Lai; Sahib Zada; Jin Seok Hwang; Trang Minh Pham; Miyong Yun; Deok Ryong Kim
Journal:  Cancers (Basel)       Date:  2018-08-16       Impact factor: 6.639

3.  Molecular characteristics of colorectal cancer in a Middle Eastern population in a single institution.

Authors:  Tony Ibrahim; Claude Saer-Ghorra; Vivane Trak-Smayra; Samah Nadiri; Charbel Yazbeck; Maria Baz; Joseph G Kattan
Journal:  Ann Saudi Med       Date:  2018 Jul-Aug       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.